
CME Group Inc.: shareholders and insiders
Price
$308.66
November 19, 2026Market cap $111B
What Ploutos Investor adds for CME
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 19, 2025 to Nov 10, 2026, from their own Form 4 filings.
Bought on the market
$510.1K
1 person
Sold on the market
$36M
13 people
From Nov 19, 2025 to Nov 19, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan6%
- The rest94%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 19, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·bought $593.9K by 1 person·sold $28M by 12 people
- 2025: bought $73.0K by 1 person, sold $8.7M by 2 people
- 2026: bought $593.9K by 1 person, sold $28M by 12 people
- Nov 9, 2026Daniel G KayeDirectorKind
- Nov 2, 2026Howard J SiegelDirectorKind
- Nov 2, 2026Julie WinklerSr MD Chief Commercial OfficerKind
- Oct 27, 2026Sunil CutinhoChief Information OfficerKind
- Oct 22, 2026Martin J GepsmanDirectorKind
- Sep 25, 2026William R ShepardDirectorKind
- Sep 16, 2026Julie WinklerSr MD Chief Commercial OfficerKind
- Sep 16, 2026Ken VromanChief Transformation OfficerKind
- Sep 16, 2026Jack J TobinMD Chief Accounting OfficerKind
- Sep 16, 2026Suzanne SpragueCOO & Global Head of ClearingKind
- Sep 16, 2026Derek SammannSr MD Gl Hd Commodities MktsKind
- Sep 16, 2026Timothy Francis McCourtSr MD Global Head Equity & FXKind
- Sep 16, 2026John Clifford MarcheseSr MD, General CounselKind
- Sep 16, 2026Lynne FitzpatrickPresident and CFOKind
- Sep 16, 2026Michael G. DennisGlobal Head of Fixed IncomeKind
- Sep 16, 2026Sunil CutinhoChief Information OfficerKind
- Sep 15, 2026Julie WinklerSr MD Chief Commercial OfficerKind
- Sep 15, 2026Julie WinklerSr MD Chief Commercial OfficerKind
- Sep 15, 2026Julie WinklerSr MD Chief Commercial OfficerKind
- Sep 15, 2026Julie WinklerSr MD Chief Commercial OfficerKind
- Sep 15, 2026Ken VromanChief Transformation OfficerKind
- Sep 15, 2026Ken VromanChief Transformation OfficerKind
- Sep 15, 2026Ken VromanChief Transformation OfficerKind
- Sep 15, 2026Ken VromanChief Transformation OfficerKind
- Sep 15, 2026Jack J TobinMD Chief Accounting OfficerKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | Daniel G KayeDirector | 532 | $304.17 | $161.8K | Form 4 | |
| Nov 2, 2026 | Howard J SiegelDirector | 2,000 | $303.00 | $606.0K | Form 4 | |
| Nov 2, 2026 | Julie WinklerSr MD Chief Commercial Officer | 10.1K | $305.15 | $3.1M | Form 4 | |
| Oct 27, 2026 | Sunil CutinhoChief Information Officer | 5,000 | $298.70 | $1.5M | Form 4 | |
| Oct 22, 2026 | Martin J GepsmanDirector | 400 | $302.50 | $121.0K | Form 4 | |
| Sep 25, 2026 | William R ShepardDirector | 293 | $268.76 | $78.6K | Form 4 | |
| Sep 16, 2026 | Julie WinklerSr MD Chief Commercial Officer | 359 | $272.46 | $97.8K | Form 4 | |
| Sep 16, 2026 | Ken VromanChief Transformation Officer | 308 | $272.46 | $83.9K | Form 4 | |
| Sep 16, 2026 | Jack J TobinMD Chief Accounting Officer | 51 | $272.46 | $13.9K | Form 4 | |
| Sep 16, 2026 | Suzanne SpragueCOO & Global Head of Clearing | 308 | $272.46 | $83.9K | Form 4 | |
| Sep 16, 2026 | Derek SammannSr MD Gl Hd Commodities Mkts | 359 | $272.46 | $97.8K | Form 4 | |
| Sep 16, 2026 | Timothy Francis McCourtSr MD Global Head Equity & FX | 364 | $272.46 | $99.2K | Form 4 | |
| Sep 16, 2026 | John Clifford MarcheseSr MD, General Counsel | 44 | $272.46 | $12.0K | Form 4 | |
| Sep 16, 2026 | Lynne FitzpatrickPresident and CFO | 359 | $272.46 | $97.8K | Form 4 | |
| Sep 16, 2026 | Michael G. DennisGlobal Head of Fixed Income | 274 | $272.46 | $74.7K | Form 4 | |
| Sep 16, 2026 | Sunil CutinhoChief Information Officer | 359 | $272.46 | $97.8K | Form 4 | |
| Sep 15, 2026 | Julie WinklerSr MD Chief Commercial Officer | 2,864 | $275.09 | $787.9K | Form 4 | |
| Sep 15, 2026 | Julie WinklerSr MD Chief Commercial Officer | 373 | $275.09 | $102.6K | Form 4 | |
| Sep 15, 2026 | Julie WinklerSr MD Chief Commercial Officer | 361 | $275.09 | $99.3K | Form 4 | |
| Sep 15, 2026 | Julie WinklerSr MD Chief Commercial Officer | 320 | $275.09 | $88.0K | Form 4 | |
| Sep 15, 2026 | Ken VromanChief Transformation Officer | 2,592 | $275.09 | $713.0K | Form 4 | |
| Sep 15, 2026 | Ken VromanChief Transformation Officer | 320 | $275.09 | $88.0K | Form 4 | |
| Sep 15, 2026 | Ken VromanChief Transformation Officer | 309 | $275.09 | $85.0K | Form 4 | |
| Sep 15, 2026 | Ken VromanChief Transformation Officer | 274 | $275.09 | $75.4K | Form 4 | |
| Sep 15, 2026 | Jack J TobinMD Chief Accounting Officer | 700 | $275.09 | $192.6K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 29, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by CME's officers and directors from 2006 up to November 18, 2025, 20 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 15 more, back to 2006
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Vanguard Capital ManagementShare of class7.45%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | 7.45% | 27.04M | Apr 29, 2026 | 13G |
Fell to 5% or less (1)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
- The Vanguard Group0.00%Mar 26, 202613G/A
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Baupost (Klarman)In the quarter+11%
- Point72 (Cohen)In the quarter+726%
- Citadel Advisors (Griffin)In the quarter+303%
- Millennium Mgmt (Englander)In the quarter+612%
- D.E. ShawIn the quarter+860%
- Renaissance TechnologiesIn the quarter-30%
- AQR CapitalIn the quarter+2.3%
- Viking Global (Halvorsen)In the quarter
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Baupost (Klarman) | 685.4K | +11% | $180M | 3.56% |
| Point72 (Cohen) | 743.7K | +726% | $164M | 0.25% |
| Citadel Advisors (Griffin) | 1.51M | +303% | $332M | 0.19% |
| Millennium Mgmt (Englander) | 1.20M | +612% | $264M | 0.18% |
| D.E. Shaw | 1.32M | +860% | $292M | 0.18% |
| Renaissance Technologies | 474.6K | -30% | $124M | 0.17% |
| AQR Capital | 2.03M | +2.3% | $448M | 0.16% |
| Viking Global (Halvorsen) | 153.0K | $34M | 0.10% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 1.39% of its shares outstanding were held short, -9.7% since the report before.
- Shares held short
- 4.99M
- 1.39%
- Since the report before5.53M on Sep 30, 2026
- -9.7%
- 2.6
- 1.93M
- More days to cover thanof 4,578 US-listed companies with enough volume
- 30%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 3.60M
- Nov 15, 2023: Shares held short 3.44M
- Nov 30, 2023: Shares held short 3.53M
- Dec 15, 2023: Shares held short 3.91M
- Dec 29, 2023: Shares held short 4.05M
- Jan 12, 2024: Shares held short 3.79M
- Jan 31, 2024: Shares held short 3.44M
- Feb 15, 2024: Shares held short 3.03M
- Feb 29, 2024: Shares held short 3.32M
- Mar 15, 2024: Shares held short 3.74M
- Mar 28, 2024: Shares held short 4.42M
- Apr 15, 2024: Shares held short 3.55M
- Apr 30, 2024: Shares held short 3.35M
- May 15, 2024: Shares held short 3.92M
- May 31, 2024: Shares held short 5.08M
- Jun 14, 2024: Shares held short 5.96M
- Jun 28, 2024: Shares held short 4.51M
- Jul 15, 2024: Shares held short 4.63M
- Jul 31, 2024: Shares held short 3.46M
- Aug 15, 2024: Shares held short 3.84M
- Aug 30, 2024: Shares held short 3.89M
- Sep 13, 2024: Shares held short 3.83M
- Sep 30, 2024: Shares held short 3.64M
- Oct 15, 2024: Shares held short 3.63M
- Oct 31, 2024: Shares held short 3.83M
- Nov 15, 2024: Shares held short 3.81M
- Nov 29, 2024: Shares held short 4.90M
- Dec 13, 2024: Shares held short 4.73M
- Dec 31, 2024: Shares held short 4.32M
- Jan 15, 2025: Shares held short 4.82M
- Jan 31, 2025: Shares held short 4.48M
- Feb 14, 2025: Shares held short 5.02M
- Feb 28, 2025: Shares held short 5.01M
- Mar 14, 2025: Shares held short 5.51M
- Mar 31, 2025: Shares held short 5.69M
- Apr 15, 2025: Shares held short 4.96M
- Apr 30, 2025: Shares held short 5.03M
- May 15, 2025: Shares held short 4.74M
- May 30, 2025: Shares held short 5.00M
- Jun 13, 2025: Shares held short 5.67M
- Jun 30, 2025: Shares held short 5.24M
- Jul 15, 2025: Shares held short 4.73M
- Jul 31, 2025: Shares held short 5.42M
- Aug 15, 2025: Shares held short 5.08M
- Aug 29, 2025: Shares held short 4.52M
- Sep 15, 2025: Shares held short 4.63M
- Sep 30, 2025: Shares held short 4.13M
- Oct 15, 2025: Shares held short 4.49M
- Oct 31, 2025: Shares held short 4.11M
- Nov 14, 2025: Shares held short 5.41M
- Nov 28, 2025: Shares held short 4.95M
- Dec 15, 2025: Shares held short 6.16M
- Dec 31, 2025: Shares held short 5.00M
- Jan 15, 2026: Shares held short 4.21M
- Jan 30, 2026: Shares held short 5.21M
- Feb 13, 2026: Shares held short 5.37M
- Feb 27, 2026: Shares held short 4.95M
- Mar 13, 2026: Shares held short 5.57M
- Mar 31, 2026: Shares held short 4.70M
- Apr 15, 2026: Shares held short 4.80M
- Apr 30, 2026: Shares held short 4.10M
- May 15, 2026: Shares held short 4.78M
- May 29, 2026: Shares held short 4.57M
- Jun 15, 2026: Shares held short 5.21M
- Jun 30, 2026: Shares held short 6.01M
- Jul 15, 2026: Shares held short 5.84M
- Jul 31, 2026: Shares held short 6.21M
- Aug 14, 2026: Shares held short 5.20M
- Aug 31, 2026: Shares held short 5.63M
- Sep 15, 2026: Shares held short 5.80M
- Sep 30, 2026: Shares held short 5.53M
- Oct 15, 2026: Shares held short 4.99M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading42.3% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 42.3% of the shares in the reported trades were short sales, against 42.1% in the 14 before.
- Last 14 sessionsOct 30, 2026 – Nov 18, 2026
- 42.3%
- The 14 beforeOct 12, 2026 – Oct 29, 2026
- 42.1%
- Change
- +0.2 pts
- Short sales a dayon average, of 684.0K shares
- 289.2K
- More than atof 3,656 US-listed companies, same days
- 25%
- Median of alleight in ten from 34.4% to 63.7%
- 50.3%
- Short sales
- Oct 12, 2026: Short sales 42.7%
- Oct 13, 2026: Short sales 51.3%
- Oct 14, 2026: Short sales 51.8%
- Oct 15, 2026: Short sales 40.7%
- Oct 16, 2026: Short sales 44.6%
- Oct 19, 2026: Short sales 46.7%
- Oct 20, 2026: Short sales 44.8%
- Oct 21, 2026: Short sales 30.2%
- Oct 22, 2026: Short sales 32.4%
- Oct 23, 2026: Short sales 46.8%
- Oct 26, 2026: Short sales 39.4%
- Oct 27, 2026: Short sales 48.6%
- Oct 28, 2026: Short sales 35.8%
- Oct 29, 2026: Short sales 35.5%
- Oct 30, 2026: Short sales 52.8%
- Nov 2, 2026: Short sales 37.8%
- Nov 3, 2026: Short sales 48.7%
- Nov 4, 2026: Short sales 47%
- Nov 5, 2026: Short sales 37.5%
- Nov 6, 2026: Short sales 38.9%
- Nov 9, 2026: Short sales 34.4%
- Nov 10, 2026: Short sales 33.5%
- Nov 11, 2026: Short sales 34%
- Nov 12, 2026: Short sales 42.3%
- Nov 13, 2026: Short sales 47.1%
- Nov 16, 2026: Short sales 46.7%
- Nov 17, 2026: Short sales 37.5%
- Nov 18, 2026: Short sales 55.4%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- William R ShepardDirectorDirectly3,621
- William W HobertDirectorDirectly127.7K
- Terrence A DuffyChairman and CEODirectly62.4K
- Patrick J MulchroneDirectorDirectly54.1K
- Bryan T DurkinDirectorDirectly43.7K
- Larry G GerdesDirectorDirectly36.7K
- Derek SammannSr MD Gl Hd Commodities MktsDirectly25.8K
- Hilda Harris PiellSr MD & Chief HR OfficerDirectly27.7K
- Lynne FitzpatrickSr MD Chief Financial OfficerDirectly26.7K
- Jack J TobinMD Chief Accounting OfficerDirectly25.8K
- Martin J GepsmanDirectorDirectly25.2K
- Julie WinklerSr MD Chief Commercial OfficerDirectly21.5K
- Ken VromanChief Transformation OfficerDirectly20.2K
- Sunil CutinhoChief Information OfficerDirectly20.0K
- Howard J SiegelDirectorDirectly19.9K
- Elizabeth A CookDirectorDirectly–
- Terry L SavageDirectorDirectly–
- Suzanne SpragueCOO & Global Head of ClearingDirectly15.5K
- Robert J Tierney JRDirectorDirectly14.3K
- Daniel R GlickmanDirectorDirectly14.0K
- Timothy Francis McCourtSr MD Global Head Equity & FXDirectly13.4K
- Timothy S. BitsbergerDirectorDirectly11.8K
- Michael G. DennisGlobal Head of Fixed IncomeDirectly10.7K
- Jonathan L MarcusSr MD General CounselDirectly7,192
- Charles P CareyDirectorDirectly2,131
- Patrick W MaloneyDirectorDirectly4,743
- Rahael SeifuDirectorDirectly4,739
- Deborah J LucasDirectorDirectly4,533
- Daniel G KayeDirectorDirectly4,313
- Phyllis M LockettDirectorDirectly4,285
- John Clifford MarcheseSr MD, General CounselDirectly3,598
- Dennis SuskindDirectorDirectly3,344
- Kathryn BeneshDirectorDirectly2,751
- Harold Eugene Ford Jr.DirectorDirectly2,158
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| William R ShepardDirector | 3,621 | 263.3K | Sep 25, 2026 | Form 4 |
| William W HobertDirector | 127.7K | – | Jun 25, 2026 | Form 4 |
| Terrence A DuffyChairman and CEO | 62.4K | – | Sep 15, 2026 | Form 4 |
| Patrick J MulchroneDirector | 54.1K | – | Jun 25, 2026 | Form 4 |
| Bryan T DurkinDirector | 43.7K | – | Jun 25, 2026 | Form 4 |
| Larry G GerdesDirector | 36.7K | – | Apr 25, 2025 | Form 4 |
| Derek SammannSr MD Gl Hd Commodities Mkts | 25.8K | 7,022 | Sep 16, 2026 | Form 4 |
| Hilda Harris PiellSr MD & Chief HR Officer | 27.7K | – | May 18, 2026 | Form 4 |
| Lynne FitzpatrickSr MD Chief Financial Officer | 26.7K | – | Sep 16, 2026 | Form 4 |
| Jack J TobinMD Chief Accounting Officer | 25.8K | – | Sep 16, 2026 | Form 4 |
| Martin J GepsmanDirector | 25.2K | – | Oct 22, 2026 | Form 4 |
| Julie WinklerSr MD Chief Commercial Officer | 21.5K | – | Nov 2, 2026 | Form 4 |
| Ken VromanChief Transformation Officer | 20.2K | – | Sep 16, 2026 | Form 4 |
| Sunil CutinhoChief Information Officer | 20.0K | – | Oct 27, 2026 | Form 4 |
| Howard J SiegelDirector | 19.9K | – | Nov 2, 2026 | Form 4 |
| Elizabeth A CookDirector | – | 17.9K | Sep 14, 2026 | Form 4 |
| Terry L SavageDirector | – | 17.4K | May 13, 2024 | Form 4 |
| Suzanne SpragueCOO & Global Head of Clearing | 15.5K | – | Sep 16, 2026 | Form 4 |
| Robert J Tierney JRDirector | 14.3K | – | Jun 25, 2026 | Form 4 |
| Daniel R GlickmanDirector | 14.0K | – | Jun 6, 2024 | Form 4 |
| Timothy Francis McCourtSr MD Global Head Equity & FX | 13.4K | – | Sep 16, 2026 | Form 4 |
| Timothy S. BitsbergerDirector | 11.8K | – | Jun 25, 2026 | Form 4 |
| Michael G. DennisGlobal Head of Fixed Income | 10.7K | – | Sep 16, 2026 | Form 4 |
| Jonathan L MarcusSr MD General Counsel | 7,192 | – | Mar 17, 2026 | Form 4 |
| Charles P CareyDirector | 2,131 | 4,900 | Jun 25, 2026 | Form 4 |
| Patrick W MaloneyDirector | 4,743 | – | Jun 25, 2026 | Form 4 |
| Rahael SeifuDirector | 4,739 | – | Jun 25, 2026 | Form 4 |
| Deborah J LucasDirector | 4,533 | – | Jun 25, 2026 | Form 4 |
| Daniel G KayeDirector | 4,313 | – | Nov 9, 2026 | Form 4 |
| Phyllis M LockettDirector | 4,285 | – | Jun 25, 2026 | Form 4 |
| John Clifford MarcheseSr MD, General Counsel | 3,598 | – | Sep 16, 2026 | Form 4 |
| Dennis SuskindDirector | 3,344 | – | Jun 25, 2026 | Form 4 |
| Kathryn BeneshDirector | 2,751 | – | Jun 25, 2026 | Form 4 |
| Harold Eugene Ford Jr.Director | 2,158 | – | Jun 25, 2026 | Form 4 |
A lower bound: it counts only the 34 officers and directors with a market trade since Nov 20, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
10b5-1 trading plans
Since 2023 every 10-Q and 10-K says which insiders adopted or ended a trading plan (Rule 10b5-1) in the quarter: when, for how many shares, until when. A plan explains the sales that follow months before they show up on Form 4.
- Jonathan MarcusSenior Managing Director and General CounselWhat happenedAdoptedJun 1, 2026Shares1,294
| Person | What happened | Until | Shares | Filing |
|---|---|---|---|---|
| Jonathan MarcusSenior Managing Director and General Counsel | AdoptedJun 1, 2026 | Mar 15, 2027 | 1,294 | 10-Q |
As the company states them in Item 9B of the 10-K and Part II, Item 5 of the 10-Q, with structured data. A plan allows sales on preset dates and prices. It does not say whether all of them will be executed.
Executive pay
From the Pay versus Performance table every company puts in its proxy statement since 2023: what the chief executive was paid, what was actually paid once the shares vest at year-end values, and how the stock did against the peer group the company itself picked.
$23M
Actually paid: $38M
$3.7M
Actually paid: $5.9M
$181
Peers: $165
cash earnings
$4.2B
From the proxy statement (DEF 14A) of Mar 23, 2026, as filed with the SEC with structured data. Pay in dollars. The company picks its own peer group and measure. DEF 14A
Share repurchases
How many of its own shares the company bought each quarter, at what average price, for how much, and what remains of the program its board authorized, from the table it puts in every 10-Q and 10-K.
From the "Issuer Purchases of Equity Securities" table of the 10-Qs and 10-Ks, read without a model. Only the quarters whose shares times average price agree with the cash the company says it paid for repurchases in its cash-flow statement are shown. The shares include those withheld for officers' taxes. A quarter with an accelerated repurchase shows the table's shares and the cash paid, without an average price. 21 filing(s) not shown, as the table was not read or did not agree with the cash.
The shareholders' vote on pay
The advisory say-on-pay vote at each annual meeting, as the company states it in the 8-K it files after the meeting: how many voted for and against the executives' pay. 90% is the norm. Under 70% proxy advisers expect the board to respond the next year.
- 2026May 19, 2026For88.3%
- 2025May 9, 2025For87.5%
- 2024May 13, 2024For87.2%
- 2023May 9, 2023For32.2%
- 2022May 6, 2022For23.3%
- 2021May 10, 2021For90.6%
| Year | For | Votes for | Votes against | Abstentions | Broker non-votes | Filing |
|---|---|---|---|---|---|---|
| 2026May 19, 2026 | 88.3% | 260M | 34.53M | 854.3K | – | 8-K |
| 2025May 9, 2025 | 87.5% | 251M | 36.03M | 551.2K | – | 8-K |
| 2024May 13, 2024 | 87.2% | 253M | 37.27M | 362.7K | – | 8-K |
| 2023May 9, 2023 | 32.2% | 91.53M | 193M | 959.5K | – | 8-K |
| 2022May 6, 2022 | 23.3% | 64.18M | 211M | 660.0K | – | 8-K |
| 2021May 10, 2021 | 90.6% | 247M | 25.64M | 1.15M | – | 8-K |
From the 8-K (item 5.07) the company files after each annual meeting since 2021, read from the filing's text without a model. A company that votes every three years has empty years. The vote is advisory: the board is not bound by it.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- DIVOAmplify CWP Enhanced Dividend Income ETFWeight in the fund3.98%
- IYFiShares U.S. Financials ETFWeight in the fund1.47%
- VFHVanguard Financials Index FundWeight in the fund1.14%
- XLFState Street(R) Financial Select Sector SPDR(R) ETFWeight in the fund1.05%
- SPLVInvesco S&P 500 Low Volatility ETFWeight in the fund0.94%
- USMViShares MSCI USA Min Vol Factor ETFWeight in the fund0.84%
- DYNFiShares U.S. Equity Factor Rotation Active ETFWeight in the fund0.71%
- MGVVanguard Morningstar Mega Cap Value Index FundWeight in the fund0.48%
- SPMOInvesco S&P 500 Momentum ETFWeight in the fund0.43%
- DGROiShares Core Dividend Growth ETFWeight in the fund0.43%
58 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 1,655
- Q4 2025: Managers 1,742
- Q1 2026: Managers 1,808
- Q2 2026: Managers 1,703
Institutional investors by quarter
The fund managers holding CME, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 1,703 managers held 322M shares, worth $71.3B. During the quarter 161 opened a position, 266 closed one, 651 added and 663 trimmed.
The largest holders, Q2 2026
- BlackRockIn the quarter-2.8%
- Vanguard Capital ManagementIn the quarter+1.3%
- State StreetIn the quarter+1.8%
- Morgan StanleyIn the quarter+3.4%
- Geode Capital ManagementIn the quarter+1.4%
- Vanguard Portfolio ManagementIn the quarter+1.5%
- Capital World InvestorsIn the quarter-1.6%
- JPMorgan ChaseIn the quarter-53%
- Sanders CapitalIn the quarter+22%
- Norges BankIn the quarter-14%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| BlackRock | 30.57M | -2.8% | $6.7B |
| Vanguard Capital Management | 23.66M | +1.3% | $5.2B |
| State Street | 16.35M | +1.8% | $3.6B |
| Morgan Stanley | 9.73M | +3.4% | $2.1B |
| Geode Capital Management | 9.27M | +1.4% | $2.0B |
| Vanguard Portfolio Management | 9.17M | +1.5% | $2.0B |
| Capital World Investors | 6.82M | -1.6% | $1.5B |
| JPMorgan Chase | 5.77M | -53% | $1.3B |
| Sanders Capital | 5.07M | +22% | $1.1B |
| Norges Bank | 4.82M | -14% | $1.1B |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
The full analysis
What do CME's filings show?
Who buys and sells is one part of CME's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have CME's insiders bought or sold?
From Jun 29, 2026 to Nov 10, 2026 CME's insiders bought 0 and sold $9.7M of shares on the market. 0% of the sales were under set 10b5-1 plans.
Which well-known managers hold CME?
8 of the managers we track held the shares on Sep 30, 2026. The largest position was AQR Capital's, worth $448M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.